Tumor heterogeneity and resistance in glioblastoma: the role of stem cells
Authors:
- 15 May 2025
- journal article
- review article
- Published by Springer Nature in Apoptosis
- Vol. 30 (7-8) , 1695-1729
Abstract
Glioblastoma multiforme (GBM) is one of the most aggressive and treatment-resistant brain tumor, characterized by its heterogeneity and the presence of glioblastoma stem cells (GSCs). GSCs are a subpopulation of cells within the tumor that possess self-renewal and differentiation capabilities, contributing to tumor initiation, progression, and recurrence. This review explores the unique biological properties of GSCs, including their molecular markers, signalling pathways, and interactions with the tumor microenvironment. We discuss the mechanisms by which GSCs evade conventional therapies, such as enhanced DNA repair and metabolic plasticity, which complicate treatment outcomes. Furthermore, we highlight recent advancements in identifying novel biomarkers and therapeutic targets that may improve the efficacy of treatments aimed at GSCs. The potential of targeted therapies, including immunotherapy and combination strategies, is also examined to overcome the challenges posed by GSCs. Ultimately, a deeper understanding of GSC biology is essential for developing personalized treatment approaches that can enhance patient outcomes in glioblastoma.Keywords
Funding Information
- not applicable
This publication has 314 references indexed in Scilit:
- Identification of a cancer stem cell in human brain tumors.2003
- Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cellsOncogene, 2002
- Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomasCytogenetic and Genome Research, 2001
- Expression of the neural RNA‐binding protein Musashi1 in human gliomasGlia, 2001
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- Oxidized low density lipoprotein caused CNS neuron cell deathBrain Research, 1997
- Expression of CD15 in tumours of the nervous systemJournal of Molecular Histology, 1992
- p53, guardian of the genomeNature, 1992
- CNS stem cells express a new class of intermediate filament proteinCell, 1990
- A glycerol-3-phosphate dehydrogenase null mutant in BALB/cHeA miceJournal of Biological Chemistry, 1989